Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
857064-38-1
|
| gptkbp:developedBy |
M.D. Anderson Cancer Center
|
| gptkbp:drugClass |
STAT3 inhibitor
|
| gptkbp:hasInChIKey |
QJQJQKQKQKQKQK-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C24H18N4O
|
| gptkbp:hasSMILES |
COc1ccc(cc1)c2nc3c(n2Cc4ccccc4)sc(n3)c5ccccc5
|
| https://www.w3.org/2000/01/rdf-schema#label |
WP1066
|
| gptkbp:isInvestigationalDrugFor |
gptkb:cancer
gptkb:glioblastoma |
| gptkbp:molecularWeight |
378.43 g/mol
|
| gptkbp:PubChem_CID |
11561660
DB12411 CHEMBL2105732 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
2-benzyl-3-(4-methoxyphenyl)-6-phenylimidazo[2,1-b][1,3]thiazole
|
| gptkbp:target |
gptkb:STAT3
|
| gptkbp:bfsParent |
gptkb:STAT3
|
| gptkbp:bfsLayer |
7
|